Antonio Ocejo, Hematology/Oncology fellow at Memorial Sloan Kettering Cancer Center, shared a post on X:
“Spending the day at the FDA/ASCO Fellows’ Workshop, demystifying what happens after a cancer therapy is submitted – from data review to advisory committees to approval. Highly recommend for any hem/onc fellow – great showing by ASCO TECAG! Thanks Tatiana Prowell and team for a great day!”
More from Antonio Ocejo on OncoDaily.